Epigenetics and the neurodegenerative process

被引：1

作者：

Slowikowski, Bartosz ^{[1
]}

Owecki, Wojciech ^{[2
]}

Jeske, Jan ^{[2
]}

Jezierski, Michal ^{[2
]}

Dragula, Michal ^{[2
]}

Goutor, Ulyana ^{[2
]}

Jagodzinski, Pawel P. ^{[1
]}

Kozubski, Wojciech ^{[3
]}

Dorszewska, Jolanta ^{[2
]}

机构：

[1] Poznan Univ Med Sci, Dept Biochem & Mol Biol, PL-61701 Poznan, Poland

[2] Poznan Univ Med Sci, Dept Neurol, Lab Neurobiol, PL-61701 Poznan, Poland

[3] Poznan Univ Med Sci, Chair & Dept Neurol, PL-61701 Poznan, Poland

来源：

EPIGENOMICS | 2024年 / 16卷 / 07期

关键词：

DNA; epigenetics modifications; neurodegeneration; neuroinflammation; RNA; PARKINSONS-DISEASE; DNA METHYLATION; HISTONE ACETYLATION; ALZHEIMERS-DISEASE; ALPHA-SYNUCLEIN; PROMOTER METHYLATION; VASCULAR DEMENTIA; GENE-EXPRESSION; CELL-DEATH; MECHANISMS;

D O I：

10.2217/epi-2023-0416

中图分类号：

Q3 [遗传学];

学科分类号：

071007 ; 090102 ;

摘要：

Neurological diseases are multifactorial, genetic and environmental. Environmental factors such as diet, physical activity and emotional state are epigenetic factors. Environmental markers are responsible for epigenetic modifications. The effect of epigenetic changes is increased inflammation of the nervous system and neuronal damage. In recent years, it has been shown that epigenetic changes may cause an increased risk of neurological disorders but, currently, the relationship between epigenetic modifications and neurodegeneration remains unclear. This review summarizes current knowledge about neurological disorders caused by epigenetic changes in diseases such as Alzheimer's disease, Parkinson's disease, stroke and epilepsy. Advances in epigenetic techniques may be key to understanding the epigenetics of central changes in neurological diseases. Created with with BioRender.com

引用

页码：473 / 491

页数：20

共 50 条

[1] Advances in Epigenetics and Epigenomics for Neurodegenerative Diseases
Qureshi, Irfan A.
Mehler, Mark F.
CURRENT NEUROLOGY AND NEUROSCIENCE REPORTS, 2011, 11 (05) : 464 - 473
[2] Epigenetics-Based Therapeutics for Neurodegenerative Disorders
Zihui Xu
Li, He
Jin, Peng
CURRENT GERIATRICS REPORTS, 2012, 1 (04) : 229 - 236
[3] Epigenetics-Based Therapeutics for Neurodegenerative Disorders
Zihui Xu
He Li
Peng Jin
Current Geriatrics Reports, 2012, 1 (4) : 229 - 236
[4] Neurodegenerative movement disorders: An epigenetics perspective and promise for the future
Murthy, Megha
Cheng, Yun Yung
Holton, Janice L.
Bettencourt, Conceicao
NEUROPATHOLOGY AND APPLIED NEUROBIOLOGY, 2021, 47 (07) : 897 - 909
[5] Impact of epigenetics in aging and age related neurodegenerative diseases
Gangisetty, Omkaram
Cabrera, Miguel A.
Murugan, Sengottuvelan
FRONTIERS IN BIOSCIENCE-LANDMARK, 2018, 23 : 1445 - 1464
[6] Advances in Epigenetics and Epigenomics for Neurodegenerative Diseases
Irfan A. Qureshi
Mark F. Mehler
Current Neurology and Neuroscience Reports, 2011, 11 : 464 - 473
[7] The Role of Epigenetics in Neuroinflammatory-Driven Diseases
Giallongo, Sebastiano
Longhitano, Lucia
Denaro, Simona
D'Aprile, Simona
Torrisi, Filippo
La Spina, Enrico
Giallongo, Cesarina
Mannino, Giuliana
Lo Furno, Debora
Zappala, Agata
Giuffrida, Rosario
Parenti, Rosalba
Li Volti, Giovanni
Tibullo, Daniele
Vicario, Nunzio
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2022, 23 (23)
[8] Redox Homeostasis, Gut Microbiota, and Epigenetics in Neurodegenerative Diseases: A Systematic Review
Munteanu, Constantin
Galaction, Anca Irina
Turnea, Marius
Blendea, Corneliu Dan
Rotariu, Mariana
Postaru, Madalina
ANTIOXIDANTS, 2024, 13 (09)
[9] Epigenetics and etiology of neurodegenerative diseases
Gruber, Beata M.
POSTEPY HIGIENY I MEDYCYNY DOSWIADCZALNEJ, 2011, 65 : 542 - 551
[10] Targeting epigenetics as a promising therapeutic strategy for treatment of neurodegenerative diseases
Zhang, Lan
Liu, Yi
Lu, Yingying
Wang, Guan
BIOCHEMICAL PHARMACOLOGY, 2022, 206

← 1 2 3 4 5 →